SLAMF6 as a drug-targetable suppressor of T cell immunity against cancer

Journal:
Nature
Published:
DOI:
10.1038/s41586-026-10106-5
Affiliations:
5
Authors:
8
Go to article
Institutions Authors Share
Clinical Research Institute of Montreal (IRCM), Canada
5.000000
 0.63
McGill University, Canada
1.666667
 0.21
University of Montreal (UdeM), Canada
0.666667
 0.08
University of Macau (UM), China
0.666667
 0.08
Interested in Immunology?